Comparative trial of perhexiline maleate and oxprenolol in patients with angina pectoris
- 1 October 1978
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 54 (636) , 663-667
- https://doi.org/10.1136/pgmj.54.636.663
Abstract
Summary: A random single-blind study of oxprenolol against perhexiline has been undertaken in angina pectoris. Both drugs were effective in treatment (P<0·01) but perhexiline was better than oxprenolol (P<0·05), 12 of the 14 patients preferring perhexiline. Offset against this was the greater incidence of side effects with perhexiline, including one patient who later developed peripheral neuropathy. Despite the greater efficacy of perhexiline, it is suggested that side effects should preclude its routine prescription as a drug of first choice in angina pectoris. It should remain of value in the special situations of resistant angina and angina with heart failure or bronchospasm, when its use should be carefully monitored for these side effects.Keywords
This publication has 17 references indexed in Scilit:
- Raised intracranial pressure due to perhexiline maleate.BMJ, 1978
- [Polyradiculitis, cerebellar manifestations, Parkinsonian tremor, papillary edema and hemorrhages in eye grounds during treatment with perhexilline maleate: regressive pathology].1977
- [Peripheral neuropathies caused by perhexiline maleate. Apropos of 7 cases].1976
- [Letter: Hypoglycemia after perhexiline maleate].1975
- [Letter: Weight reduction and perhexiline maleate].1974
- [Letter: Secondary but reversible effects of perhexilin administration].1973
- The action of perhexiline maleate in patients with anginaAmerican Heart Journal, 1973
- Proceedings: Clinical results with a new antianginal drug (perhexiline maleate).1973
- Clinical Evaluation of Perhexiline Maleate in Patients with Angina PectorisBMJ, 1971
- Comparison of Adrenergic Beta-blocking Drugs in Angina PectorisBMJ, 1971